Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Robustness of NeuroMark-derived functional networks to fMRI spatial normalization across the human lifespan.

NeuroImage·2026
Same author

Nonparametric motion control in functional connectivity studies in children with autism spectrum disorder.

Biometrics·2026
Same author

Dynamics of infant white matter maturation from birth to 6 months.

Communications biology·2026
Same author

Robustness of NeuroMark-Derived Functional Networks to fMRI Spatial Normalization Across the Human Lifespan.

bioRxiv : the preprint server for biology·2026
Same author

Explicitly nonlinear fMRI networks reveal hidden trajectories of infant brain development.

bioRxiv : the preprint server for biology·2026
Same author

Genetic insights on the mechanisms of human cortical folding.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 1, 2026

Automated Sample Multiplexing by using Combined Precursor Isotopic Labeling and Isobaric Tagging (cPILOT)
09:24

Automated Sample Multiplexing by using Combined Precursor Isotopic Labeling and Isobaric Tagging (cPILOT)

Published on: December 18, 2020

Automated luminescence-based cytochrome P450 profiling using a simple, elegant robotic platform.

Brad Larson1, Peter Banks, James J Cali

  • 1BioTek Instruments, Inc., Highland Park, Winooski, VT 05404, USA. arsonb@biotek.com

Journal of Laboratory Automation
|May 26, 2011
PubMed
Summary

Automated assays efficiently screen drug compounds for cytochrome P450 (CYP) inhibition. This robotic platform enables early prediction of drug-drug interactions, reducing late-stage failures in drug discovery.

More Related Videos

High-throughput Functional Screening using a Homemade Dual-glow Luciferase Assay
12:55

High-throughput Functional Screening using a Homemade Dual-glow Luciferase Assay

Published on: June 1, 2014

Monitoring Cell-autonomous Circadian Clock Rhythms of Gene Expression Using Luciferase Bioluminescence Reporters
10:38

Monitoring Cell-autonomous Circadian Clock Rhythms of Gene Expression Using Luciferase Bioluminescence Reporters

Published on: September 27, 2012

Related Experiment Videos

Last Updated: Jun 1, 2026

Automated Sample Multiplexing by using Combined Precursor Isotopic Labeling and Isobaric Tagging (cPILOT)
09:24

Automated Sample Multiplexing by using Combined Precursor Isotopic Labeling and Isobaric Tagging (cPILOT)

Published on: December 18, 2020

High-throughput Functional Screening using a Homemade Dual-glow Luciferase Assay
12:55

High-throughput Functional Screening using a Homemade Dual-glow Luciferase Assay

Published on: June 1, 2014

Monitoring Cell-autonomous Circadian Clock Rhythms of Gene Expression Using Luciferase Bioluminescence Reporters
10:38

Monitoring Cell-autonomous Circadian Clock Rhythms of Gene Expression Using Luciferase Bioluminescence Reporters

Published on: September 27, 2012

Area of Science:

  • Drug Discovery and Development
  • Pharmacology
  • Biochemistry

Background:

  • Cytochrome P450 (CYP) enzymes are crucial in drug metabolism.
  • Inhibition of CYP enzymes by drug candidates can lead to adverse drug-drug interactions.
  • Early identification of CYP inhibition is vital to prevent costly late-stage drug development failures.

Purpose of the Study:

  • To demonstrate the automation of cytochrome P450 (CYP) profiling using a robotic platform.
  • To enable high-throughput screening of lead compounds for CYP inhibitory effects.
  • To facilitate early prediction of potential drug-drug interactions.

Main Methods:

  • Development and implementation of a robotic platform for automated compound titration and assay component transfer.
  • Utilized a "mix and read" assay format for increased efficiency.
  • Determined IC50 values using recombinant CYP enzymes (CYP3A4, -2C9, -2D6) and specific luminogenic substrates.

Main Results:

  • Successfully automated the CYP profiling process, including compound handling and assay execution.
  • Demonstrated the ability to profile compounds against multiple CYP enzymes (CYP3A4, -2C9, -2D6) on a single 384-well plate.
  • Generated IC50 values for small molecule drugs, indicating their inhibitory potential.

Conclusions:

  • The automated robotic platform provides a robust and efficient method for CYP profiling in early drug discovery.
  • This automated approach supports the testing of substantial compound numbers, aiding in the prediction of drug-drug interactions.
  • Streamlining CYP inhibition assays contributes to minimizing risks and costs throughout the drug development pipeline.